CHINARES PHARMA (03320): KPC Pharmaceuticals, Inc.'s shareholders' net profit in 2025 is expected to be approximately 350 million yuan, a decrease of 46% year-on-year.

20:07 19/03/2026

China Resources Pharmaceuticals (03320) announced the performance of Kun Pharmaceutical Group in 2025. The total operating income is approximately 6.575 billion yuan, a decrease of 21.74% year-on-year. The net profit attributable to shareholders of the listed company is about 350 million yuan, a decrease of 46% year-on-year. Earnings per share is 0.46 yuan, and a cash dividend of 1.80 yuan (including tax) is distributed for every 10 shares held.

CHINARES PHARMA (03320) announced the performance of KPC Pharmaceuticals, Inc. in 2025, with total operating revenue of approximately 6.575 billion yuan, a year-on-year decrease of 21.74%; the net profit attributable to shareholders of the listed company is approximately 350 million yuan, a year-on-year decrease of 46%; basic earnings per share is 0.46 yuan, and the dividend is 1.80 yuan per 10 shares (including tax).

VICTORY SEC (08540) will distribute a final dividend of HK$0.03 per share on July 2nd.

K W NELSON GP (08411) will distribute a final dividend of HK$0.006 per share on June 22nd.

MMG(01208): Khoemacau Copper signs agreement with MCC 23 to build KHOEMACAU concentrator plant, external ramp and mining infrastructure in Botswana.

VICTORY SEC (08540) will distribute a final dividend of HK$0.03 per share on July 2nd.

K W NELSON GP (08411) will distribute a final dividend of HK$0.006 per share on June 22nd.

MMG(01208): Khoemacau Copper signs agreement with MCC 23 to build KHOEMACAU concentrator plant, external ramp and mining infrastructure in Botswana.